PEPCID AC FILM-COATED 10 Milligram Film Coated Tablet

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

FAMOTIDINE

Available from:

McNeil Healthcare (Ireland) Ltd

ATC code:

A02BA03

INN (International Name):

FAMOTIDINE

Dosage:

10 Milligram

Pharmaceutical form:

Film Coated Tablet

Prescription type:

Product not subject to medical prescription

Therapeutic area:

H2-receptor antagonists

Authorization status:

Authorised

Authorization date:

2011-01-21

Patient Information leaflet

READ ALL OF THIS LEAFL ET CAREFULLY BEFORE YOU START TAKING
THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
Always take this medicine exactly as described in this
leafl et or as your doctor or pharmacist has told you.
■ Keep this leafl et. You may need to read it again.
■ Ask your pharmacist if you need more information or
advice.
■ If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leafl et. See section 4.
▶
■ You must talk to a doctor if you do not feel better or
if you feel worse after 14 days.
WHAT IS IN THIS LEAFL ET:
1. What Pepcid AC is and what it is used for
2. What you need to know before you take Pepcid AC
3. How to take Pepcid AC
4. Possible side effects
5. How to store Pepcid AC
6. Contents of the pack and other information
1 WHAT PEPCID AC IS WHAT IT IS USED
FOR
Pepcid AC tablets are for the short-term symptomatic
relief of heartburn, indigestion (dyspepsia) and excess
acid. They can prevent these symptoms when they follow
a meal or beverage (drink) known to trigger them. Pepcid
AC taken before the evening meal can also prevent night-
time symptoms which disturb sleep when this is associated
with food or drink.
Pepcid AC provides relief from the symptoms of heartburn
and indigestion with just one small tablet. It has been
clinically proven to control excess stomach acid for nine
hours throughout the day and for 12 hours throughout the
night. The active ingredient in your medicine is famotidine.
This belongs to a group of medicines known as
“H2 blockers”. Unlike antacids which neutralise acids,
famotidine controls the production of excess acid and
treats the cause of pain and discomfort.
You must talk to a doctor if you do not feel better or if you
feel worse after 14 days.
2 WHAT YOU NEED TO KNOW BEFORE YOU
TAKE PEPCID AC
This medicine is suitable for most people, but a few
people should not use it. If you are in any doubt, talk to
your doctor or pharmacist.
DO NOT TAKE THIS MEDICINE….
■ If you

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Pepcid AC
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 10 mg famotidine
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film-coated tablet.
Pale-rose, rounded-square tablet with FA10 engraved on one side.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
The short-term symptomatic relief of heartburn, indigestion
(dyspepsia) and excess acid.
Prevention of these symptoms when associated with meals including
nocturnal symptoms.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
Adults and children 16 years of age or older:
DOSAGE: 10mg
DOSAGE INTERVAL:
1 tablet (10mg) for symptomatic relief of heartburn, indigestion
(dyspepsia) and excess acid.
or
1 tablet (10mg) taken 15 minutes prior to meals to prevent these
symptoms.
or
1 tablet (10mg) taken within one hour before the evening meal for
prevention of nocturnal symptoms.
Maximum intake in 24 hours: 2 tablets (20mg).
The maximum treatment period is 2 weeks.
Special populations
_Elderly_
No dosage adjustment is necessary for the elderly.
_Paediatric populations_
Pepcid AC is not recommended for use in children less than 16 years of
age.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_9_
_/_
_0_
_6_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_2_
_1_
_8_
_9_
_2_
_4_
_6_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
The safety and effectiveness of oral famotidine have not been
established in paediatric patients.
_Renal Imp